In the second study of nine healthcare workers with papillary thyroid carcinoma (PTC) exposed to LDIR, BRAF V600 genetic alterations were revealed in four cases, including one with RET/PTC1 fusion, and in one case, point mutations and fusions were found. Here, RET is linked to thyroid gland papillary carcinoma.